Mayne Pharma reports $92 million loss

adelaide Friday August 21, 2020

Adelaide-based pharmaceutical company Mayne Pharma has reported a $92.8 million loss for the 2020 financial year, driven by asset write downs in its generic medicines business.

Mayne Pharma CEO Scott Richards says COVID-19 is presenting unprecedented challenges for the business. Picture: Tracey Nearmy/AAP.

The Salisbury South company, which also has signifi…

Read the full article at: https://indaily.com.au/news/business/2020/08/21/mayne-pharma-reports-92-million-loss/

Mayne Pharma reports $92 million loss – InDaily

Related Posts